Epocrates , Nasdaq: EPOC
Provides an ad-supported mobile drug reference app for healthcare professionals.
Industry: Technology
First Day Return: +37.3%
Industry: Technology
EPOC
Provides an ad-supported mobile drug reference app for healthcare professionals.
| IPO Data | |
|---|---|
| IPO File Date | 07/16/2010 |
| Offer Price | $16.00 |
| Price Range $13.00 - $15.00 | |
| Offer Shares (mm) | 5.4 |
| Deal Size ($mm) | $86 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/01/2011 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $86 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Mateo, CA, United States |
| Founded | 1998 |
| Employees at IPO | n/a |
| Website www.epocrates.com | |
IPO News for Epocrates
Epocrates (EPOC) Performance
